References

  1. Sharp GC, Irvin WS, Tan EM et al. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972; 52(2):148-59. PubMed | Google Scholar

  2. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol. 1989 Mar; 16(3):328-34. PubMed | Google Scholar

  3. Kasukawa R, Tojo T, Miyawaki S, et al. mixed connective tissue disease: A preliminary diagnostic criteria. Jap J Rheumatol. 1988;31(2):219-26. PubMed | Google Scholar

  4. Kahn MF, AppleboomT. Syndrome de Sharp In: Kahn MF, Peltier AP, Meyer O, Piette JC. Les maladies systémiques -5ème édition. 1991; Paris Flammarion: 545-56. PubMed | Google Scholar

  5. Alcaix D, Bourgeois P. Connectivites mixtes: appareil locomoteur. Encycl Med Chir. 1994; 5p: 14-244-B-10. PubMed | Google Scholar

  6. Hajas A, Szodoray P, Nakken B et al. Clinical course, prognosis and causes of death in Mixed Connective Tissue Disease. J Rheumatol. 2013; 40 (7):1134-1142. PubMed | Google Scholar

  7. Cappelli S, Bellando Randone S, Martinovic D, et al. "To be or not to be", ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012; 41 (4):589-98. PubMed | Google Scholar

  8. Gunnarsson R, Molberg O, Gilboe IM et al. The prevalence and incidence of MCTD: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011; 70 (6):1047-51. PubMed | Google Scholar

  9. Paradowska-Gorycka A, Stypinska B, Olesinska M et al. Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients. HLA. 2016; 87(1):13-18. PubMed | Google Scholar

  10. Shi YH, Li R, Chen S, Su Y, Jia Y. Analysis of clinical features and the outcome in 91 cases of mixed connective tissue disease. Beijing Da Xue Xue Bao. 2012; 44(2):270-4. PubMed | Google Scholar

  11. Doria A, Ghirardello A, De Zambiasi P, Ruffatti A, Gambardi PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol. 1992 Feb;19(2):259-64. PubMed | Google Scholar

  12. Ungprasert P, Crowson CS, Chowdhary VR et al. Epidemyology of mixed connective tissue disease 1985-2014: a population based study. Arthritis Care Res. 2016; 68 (4):1843-8. PubMed | Google Scholar

  13. Maldonado ME, Perez M, Pignac-Kobinger J et al. Clinical and immunologic manifestations of Mixed Connective Tissue Disease in a Miami population compared to a Midwestern US Caucasian population. J Rheumatol. 2008; 35 (3):429-37. PubMed | Google Scholar

  14. Diallo S, Ka MM, Pouye A et al. Le syndrome de Sharp chez le noir Africain: à propos de 3 nouvelles observations Sénégalaises. Med Afr Noire. 2008; 55(12):623-30. PubMed | Google Scholar

  15. Diallo S, Kane A, Dieng MT et al. Les connectivites chez le noir africain Sénégalais: à propos de 260 observations colligées en 10 ans (abstract). Rev Rhum Ed Fr. 1996; 63:906. PubMed | Google Scholar

  16. Ndiaye M, Hane AA, Dieng MT et al. Sharp syndrome complicating pulmonary tuberculosis: about a case. Dakar Med. 1999; 44(2):236-9. PubMed | Google Scholar

  17. Houzou P, Oniankitan O, Kakpovi K et al. Rheumatic diseases profile of 13577 West African patients. Tunis Med. 2013; 91(01):16-20. PubMed | Google Scholar

  18. Mijiyawa M, Amanga K, Oniankitan OI, Pitché P, Tchangaï-Walla K. Connectivite tissue diseases in the hospital outpatient service in Lomé (Togo). Rev Med Interne. 1999; 20(1):13-7. PubMed | Google Scholar

  19. Ouedraogo DD, Korsaga-Somé N, Zabsonné Tiendrébéogo J et al. Les connectivites en pratique hospitalière à Ouagadougou (Burkina Faso). Med Sante Trop. 2014; 24(3):271-4. PubMed | Google Scholar

  20. Noche CD, Kagmeni G, Donyoma V, Bella AL, Mvogo CE, Singwe-Ngandeu M. Ophtalmic manifestations in chronic inflammatory rheumatic diseases at a referal hospital of Yaounde, Cameroon. Occul Immunol Inflamm. 2016; 6:1-6. PubMed | Google Scholar

  21. Daboiko JC, Eti E, Dollo Yapi I, Ouali B, Ouattatra B, Kouakou N'zué M. Les affections rhumatologiques inflammatoires ayant motivé une hospitalisation au centre hospitalo-universitaire de Cocody (Abidjan) entre mars 1998 et mars 2000. Rev Rhum. 2004; 71:1215-20. PubMed | Google Scholar

  22. Lutalo SK. Chronic inflammatory rheumatic diseases in black Zimbabweans. Ann Rheum Dis. 1985 Feb;44(2):121-5. PubMed | Google Scholar

  23. Zomalheto Z, Assogba M, Agbodande A, Atadokpede F, Gounongbe M, Avimadje M. Pattern of systemic lupus erythematosus in Benin and West African patients. Tunis Med. 2014 Dec; 92(12):707-10. PubMed | Google Scholar

  24. Iba Ba J, Nzenze JR, Metoule A, Missounga L et al. Dermatomyosite et polymyosite : 15 cas au Gabon. Med Afr Noire. 2013; 60 (5):223-9. PubMed | Google Scholar

  25. Flam ST, Gunnarson R, Garen T. The HLA profiles of MCTD differ distinctly from the profiles of clinicaly related connective tissue diseases. Rheumatology (Oxford). 2015; 54(3):528-35. PubMed | Google Scholar

  26. Gunnarsson R, Hetlevik SO, Lilleby V, Molberg O. Mixed connective tissue disease. Best Pract Clin Rheumatol. 2016; 30(1):95-111. PubMed | Google Scholar

  27. Takehana Y, Douvas A. Cross-reactivity between autoimmune anti-U1sn RNP antibodies and neutralizing epitopes of HIV-1 gp 120/41. AIDS Res Hum Retroviruses. 1994; 10(7):253-62. PubMed | Google Scholar

  28. Fujiwara H, Nakamura D, Kukita T, et al. immunosuppressive treatment for MCTD may facilitate the development of adult T cell leukemia / lymphoma in a HTLV-I carrier. Intern Med. 2006; 45 (5): 297-301. PubMed | Google Scholar

  29. Tikly M, Njobvu P, Mc Gill P. Spondyloarthritis in sub-Saharian Africa. Curr Rheumatol Rep. 2014; Jun;16(6):421. PubMed | Google Scholar

  30. Garcia-de la Torre M, Salazar-Paramo M, Salmon-de la Torre G. Mixed connective tissue disease : a clinico-serological study of 17 cases. Mol Biol Rep. 1996; 23(3-4):153-7. PubMed | Google Scholar

  31. Lawrence A, Aggarwal A, Misra R. MCTD: is it rare in India?. Clin Rheumatol. 2007; Feb;26(2):205-7. PubMed | Google Scholar

  32. Hayem G. Connectivites mixtes In: Guillevin L, Meyer O, Sibilia J : Traité des maladies et syndromes systémiques. 5ème édition. 2008; Paris, Médecine-Sciences Flammarion; 516-31. PubMed | Google Scholar

  33. Tellier S, Bader-Meunier B, Quartier P et al. Initial presentation and outcome of pediatric-onset mixed connective tissue disease: a French multicenter retrospective study. Joint Bone Spine. 2016; May; 83(3):369-71. PubMed | Google Scholar

  34. Rayes HA, Al-Sheikh A, Al Dalaan A, Al Saleh S. Mixed connective tissue disease: the King Faisal Specialist hospital experience. Ann Saoudi Med. 2002; Jan-Mar; 22(1-2):43-6. PubMed | Google Scholar

  35. Gunnarsson R, Andreassen K, Molberg O et al. Prevalence of pulmonary hypertension in a unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicenter study and review of current literature. Rheumatology. 2013; 52 (6):1208-13. PubMed | Google Scholar

  36. Kowal-Bilecka D, Distler O. Use of methotrexate in patients with sclerodermia and mixed connective tissue disease. Clin Exp Rheumatol. 2010; 28 (5Suppl 61):S160-3. PubMed | Google Scholar